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Abstract
Objectives: This study examined whether psychiatric patients assigned to community treatment 
orders (CTOs), outpatient commitment in Victoria, Australia, have a greater need for treatment to 
protect their health and safety than patients not assigned to CTOs. It also considered whether such 
treatment is provided in a least restrictive manner—that is, in a way that contributes to reduced use 
of psychiatric hospitalization.
Methods: The sample included 11,424 patients first placed on a CTO between 2000 and 2010, 
and 16,161 patients not placed on a CTO. Need for treatment was independently assessed with the 
Health of the Nation Outcome Scales (HoNOS) at hospital admission and at discharge. Ordinary 
least-squares and Poisson regressions were used to assess savings in hospital days attributable to 
CTO placement.
Results: HoNOS ratings indicated that at admission and discharge, the CTO cohort’s need for 
treatment exceeded that of the non-CTO cohort, particularly in areas indicating potential 
dangerous behavior. When analyses adjusted for the propensity to be selected into the CTO cohort 
and other factors, the mean duration of an inpatient episode was 4.6 days shorter for the CTO 
cohort than for the non-CTO cohort, and a reduction of 10.4 days per inpatient episode was 
attributable to each CTO placement.
Conclusions: CTO placement may have helped patients with a greater need for treatment to 
experience shorter hospital stays. Whether the CTO directly enabled the fulfillment of unsought 
but required treatment needs that protected patient health and safety is a question that needs to be 
addressed in future research.
Outpatient commitment provisions have been written into law around the world (1) and exist 
in 45 U.S. states and the District of Columbia (2). These provisions have been described as 
assisted treatment (3), a means to deliver involuntary treatment (4), and a way to engender 
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treatment compliance (5). In civil commitment law, outpatient orders are almost universally 
recognized as “a least restrictive alternative to psychiatric hospitalization” for persons 
meeting the involuntary civil commitment standard of the jurisdiction. Outpatient 
commitment, which is initiated by a community treatment order (CTO) in Victoria, 
Australia, and most Commonwealth nations, is carried out in two primary ways. First, it is a 
form of conditional release whereby a patient is placed on an order after involuntary 
hospitalization as part of an aftercare plan and as a means to shorten the duration of the 
current hospital episode. This is by far the oldest and most used approach (6). Second, a 
patient can be placed on a CTO while living in the community as a way of avoiding 
hospitalization, although this occurs infrequently (7).
The utility of a CTO depends on the extent to which it meets the stated objectives written 
into the law (7). For individuals who refuse intervention because of their symptoms of 
mental illness, these objectives include ensuring access to needed treatment by various 
means of service, focusing on the protection of the health and safety of self and others, and 
using the least restrictive alternative to psychiatric hospitalization to accomplish these goals. 
[A description of CTO use in Victoria is included in an online supplement to this article.]
The CTO is designed to be a delivery system enabling the provision of unsought but 
required services that are thought to lead to positive health and safety outcomes with limited 
use of hospitalization (7). In fact, a CTO is typically part of a package that includes the 
hospitalization preceding it. By design, the CTO should enable savings in hospital days by 
allowing clinicians to shorten the inpatient stay it follows. It should protect against untoward 
events after the inpatient stay, with either additional service provision or, as a result of the 
additional supervision it provides, rehospitalization to prevent negative health and safety 
outcomes.
This study built on previous work (7–9) by considering the effects of various components of 
the CTO legal mandate. It analyzed a second decade of new data to attempt to replicate the 
earlier findings and to add to the understanding of how CTOs fulfill the stated objectives 
written into the law. In 2000, at the outset of the decade under study, Victoria closed all its 
state hospitals and began relying on general hospital psychiatric services and CTOs to help 
ensure delivery of needed treatment objectives in a fully integrated health and mental health 
care system. This study addressed two considerations in the use of CTOs in Victoria, 
Australia. First, to what extent are patients selected for CTOs in need of treatment related to 
protecting their health and safety? Second, is the provision of such treatment delivered in a 
least restrictive manner—that is, in a way that contributes to reduced use of psychiatric 
hospitalization (10)?
METHODS
Sample
The Victorian Psychiatric Case Register/RAPID data system provides a record of the 
characteristics of all clinical contacts that occur in the State of Victoria, Australia. All 
patients who were hospitalized for psychiatric reasons between July 1, 2000, and June 30, 
2010, were identified (N=69,186), and two cohorts were drawn. The first included all 
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individuals placed on a CTO for the first time during the period (N=11,424). The second was 
a matched and randomly selected comparison cohort of persons hospitalized for psychiatric 
reasons who were never placed on a CTO (N=16,161). [Additional details about cohort 
selection are included in the online supplement.] These records were then linked to the 
records of Corrections Victoria, which document detention in police custody or prison; the 
Socio-Economic Indexes for Areas, which indicate neighborhood disadvantage (11); and the 
Australian Mental Health Outcomes and Classification Network’s (AMHOCN’S) Health of 
the Nation Outcome Scales (HoNOS) records of clinical quality-of-life assessments of 
patients who use Australia’s mental health systems.
Measuring Need for Treatment: HoNOS Item Profiles
The HoNOS is a 12-item measure of a person’s mental health, overall health, and 
relationship to their social context—their quality of life and its potential relationship to 
mental illness (12). The HoNOS has established reliability and validity (13). Clinicians in 
Australia—those who are AMHOCN-trained and retrained—complete HoNOS assessments 
routinely as part of an effort to evaluate the national mental health system. The assessing 
clinician, usually a psychiatric nurse, is not the same clinician who makes the 
recommendation or decision regarding a CTO placement (13)—that person is a psychiatrist. 
Inclusion of these independent and routine HoNOS measurements enabled an evaluation of 
patients’ need for treatment at hospital admission and at hospital discharge and also enabled 
a determination of whether the judgment exercised in hospitalizing and placing individuals 
on CTOs was reflected in differences in patients’ observed behavioral and situational lives at 
these points in time.
Clinicians provided scores on the HoNOS items at inpatient admission and discharge, which 
is when CTO placement typically occurred for members of the CTO cohort. Individual 
HoNOS items are rated from 0, no problem, to 4, an extremely problematic situation (14). 
Clinicians completing the HoNOS determine the degree to which patients show problems 
with aggression, nonaccidental self-injury, drug or alcohol problems, cognitive problems, 
general medical illness or disability, hallucinations or delusions, depressed mood, other 
mental or behavioral problems, relationships, activities of daily living, living conditions, and 
occupation and activities. Although the total HoNOS score has been used as a measure of 
overall psychiatric morbidity (15), this usage is not recommended (16) because of the 
multidimensional structure of the instrument (17,18). In this study, HoNOS profiles, which 
were based on the maximum score that the patient received on a given item at admission and 
at discharge, were considered potential indicators of the two cohorts’ differing treatment 
needs. This procedure provided a 12-item profile of the cohorts at their worst—their most 
severe clinical assessment or their lowest quality-of-life rating. It provided a case-mix profile 
of group membership. Each item severity rating of 0 to 4 was anchored in HoNOS 
guidelines. Thus each integer rating served as an anchor point for clinicians when they 
evaluated the seriousness of the patients’ problems.
A serious problem with any HoNOS dimension would contribute to a decision of eligibility 
for CTO placement (16,17,19). The HoNOS assessment, however, is not part of the CTO 
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evaluative process in Victoria. In this study, scores on HoNOS items were the result of 
independent evaluations and were used to assess the validity of the CTO process.
Measuring Treatment Delivery
In documenting a patient’s receipt of treatment, all treatment contacts were organized into 
episodes of care. Each hospitalization (from day of admission to day of discharge) was 
considered to be a separate inpatient episode, and each continuous period of outpatient care 
without a break in service for 90 days or more was considered to be a community care 
episode (20). Reinitiation of care after a break in service of 90 days or more was considered 
the start of a new community care episode. All occasions of community service were 
reported as community treatment days; multiple occasions of community service on the 
same day were counted as one community treatment day. Units of analysis were the same 
for both cohorts.
Analyses
All analyses were conducted with SPSS 23.0 (21). Chi-square tests and analyses of variance 
were used for descriptive statistics and group differences. Logistic regression was used to 
develop a propensity score designed to assess a patient’s probability of being selected into 
the CTO cohort [see online supplement for details]. Ordinary least-squares (OLS) and 
Poisson regressions were used to assess savings in hospital days per average inpatient 
episode per person—given that a reduction in the duration of inpatient episodes has been 
most frequently replicated as a positive outcome of CTO assignment (7,15,22). For OLS and 
Poisson regressions, the average duration of the inpatient episode experienced by a patient 
during the study was regressed on CTO exposure over the course of the study period, 
average number of community-based treatment contacts, and the interaction of these two 
factors, after adjustment for the following: the propensity of a patient to be selected into the 
CTO sample from among patients who were hospitalized, demographic characteristics, 
potential communication barriers as a non- English speaker, socioeconomic status or 
vocational challenge, risk periods associated with the study, institutional involvement (that 
is, number of inpatient episodes or had a longer than average inpatient episode), diagnoses, 
experience of police custody or imprisonment, and a patient’s psychosocial profile reflected 
in his or her 12 HoNOS scores at both inpatient admission and release. This model was then 
rerun, substituting the number of CTO episodes that a patient experienced for “CTO 
exposure” in order to estimate the contribution of each CTO episode to reducing the average 
duration of an inpatient episode [see online supplement for more details about the theory 
used to build the model].
Ethics
The human subjects committees of the Victoria Department of Human Services, the Victoria 
Department of Jus- tice, and the University of California, Berkeley, approved study 
procedures.
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RESULTS
Data on demographic and diagnostic characteristics of the sample are presented in Table 1. 
The mean age of the sample at study outset was 34.0. More than half of the patients (56%) 
were male, were not educated beyond the 11th grade (52%), and were unemployed (60%). 
About half (49%) had never been married, and two-thirds (66%) had a diagnosis of 
schizophrenia.
Table 2 presents data on the treatment experiences of the two cohorts. Patients in the CTO 
cohort entered the mental health system at an earlier age than those in the non-CTO cohort 
(age 32.1 versus 35.5). During the study period, patients in the CTO cohort experienced 4.0 
inpatient episodes on average (range 1–65), compared with 1.3 (range 1–39) for those in the 
non-CTO cohort. The CTO cohort averaged 38.0 inpatient days per episode, compared with 
29.1 for the non-CTO cohort.
The CTO cohort experienced almost twice the number of community treatment episodes 
compared with the non-CTO group (6.0 versus 3.3), with almost 40% more treatment days 
per episode (26.6 versus 16.1). For the CTO cohort, an average of 2.3 of the community 
treatment episodes involved placement on a CTO. Overall, the CTO cohort experienced 
25,696 total CTO episodes; 39.2% (N=10,021) of the CTO episodes ended in 
rehospitalization, and only 5.9% (N=1,516) were initiated from the community (that is, 
either initiated on the same day of hospital admission—the patient was brought in and 
immediately released on a CTO—or initiated more than three days after hospital admission).
The CTO cohort entered inpatient care with clinical profile scores more severe than their 
non-CTO counterparts on all 12 HoNOS dimensions. Differences between cohorts in 
HoNOS scores on admission were statistically significant (p<.001) on all dimensions except 
for physical health, which was statistically significant at p=.002. The profile was more 
severe not only statistically but also clinically (that is, when scores are rounded to their 
nearest clinical anchor value). Although both groups manifested clinically significant 
problems at admission on all dimensions, clinically adjusted scores of the CTO group 
exceeded those of the non-CTO group on the following items: aggression, drugs and alcohol, 
cognitive dysfunction, and hallucinations or delusions (Figure 1). The scores of both groups 
indicated not only a statistically but also a clinically significant problem on the eight other 
items, sufficient to allow inpatient care recommendations (23).
HoNOS scores at discharge—the point at which CTO placement typically occurred for 
members of the CTO cohort—showed an abatement of problems associated with most 
HoNOS dimensions. However, the CTO group continued to have more severe problems than 
their non-CTO counterparts on all dimensions at discharge. The differences between cohorts 
were statistically significant differences (p<.001) on all dimensions except for other mental 
disorder (p=.009) and physical health (p=.051). In addition, compared with their non-CTO 
counterparts, the CTO patients continued to have clinically significant elevations in 
hallucinations or delusions and relationship issues (Figure 1).
Table 3 summarizes the results of the logistic regression describing patient characteristics 
that were associated with an increased likelihood of being released from inpatient care on a 
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CTO. The model evaluated 42 of 46 noncollinear variables and was significant 
(x2=9,056.94, df=42, p<.001). Patients were 5.47 times more likely to be selected for a CTO 
if they experienced a hospitalization of greater than the 34-day mean length of stay. In 
addition, the likelihood was greater (Exp(b)=1.60) with each additional hospitalization. For 
each unit increase in severity on the 4-point HoNOS item on hallucinations or delusions at 
hospital discharge, the likeli- hood of CTO assignment was increased (Exp(b)=1.28); the 
likelihood was also increased (Exp(b)=1.12) for each unit increase in severity on this item at 
hospital admission. In addition, the likelihood of CTO assignment was increased for each 
unit increase in severity at admission on the fol- lowing three items: aggression 
(Exp(b)=1.15), disturbance in relationships (Exp(b)=1.05), and cognitive disturbance 
(Exp(b)=1.03). Being a male also increased the likelihood of CTO assignment 
(Exp(b)=1.13), as did having an interpreter at the mental health tribunal hearing 
(Exp(b)=1.23).
The OLS regressions considered the role of the CTO in the duration of an inpatient episode 
when all aforementioned controls and the propensity of a patient to be selected into the CTO 
sample were taken into account (Table 4). The first model considered the overall effect of 
CTO assignment on average inpatient episode duration; its summary statistics were as 
follows: R=.704; adjusted R2=.494, F=463.84, df=44 and 20,780, p<.001. Results indicated 
that placement on a CTO resulted in 4.6 fewer days per inpatient episode over the course of 
the study period (b=−4.61, p<.001). The second model considered the impact of a given 
CTO on inpatient episode duration; its summary statistics were as follows: R=.722, adjusted 
R2=.522, F=515.66, df=44 and 20,780, p,.001. The model results indicated that each 
individual placement on a CTO resulted in a reduction of 10.4 days in the associated 
inpatient episode (b=−10.38, p,.001).
Results from the OLS regressions were replicated in the Poisson analyses. The average 
episode duration for the CTO cohort was estimated to be shorter than for the non-CTO 
cohort (Exp(b)=.960, 95% confidence interval [CI]=.955–.966), likelihood ratio 
x2=8,372.35, df=20, p<.001). Each CTO episode was associated with fewer inpatient days 
(Exp(b)=.913; CI=.911–.914, model likelihood ratio x2=8,500.39, df=45, p<.001).
DISCUSSION
This study replicated findings from an analysis of data from a previous decade in Victoria 
(7). As in the previous study, longer and repeated hospitalizations were strongly associated 
with selection for the CTO delivery system. Thus, from 2000 to 2010, it continued to be the 
case that a major consideration in the selection of individuals for placement on a CTO was 
experience of longer inpatient stays (≥34 days) and more inpatient episodes, compared with 
individuals not placed on a CTO
In terms of least restrictive care, the results seem to support the objective of providing care 
in a way that involved reduced use of psychiatric hospitalization in each episode of care. 
After the analysis adjusted for treatment history, diagnosis, demographic factors, 
psychosocial profile, prison time, cultural disadvantage, social disadvantage of the postal 
code in which the patient resided, and the propensity of a patient to be selected into the CTO 
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sample, placement on a CTO resulted in 4.6 fewer days per inpatient episode over the course 
of the study and a reduction of 10.4 inpatient days per CTO episode. These findings seem to 
confirm the goal of using CTOs to reduce the duration of inpatient episodes. They also 
replicate earlier findings in Victoria (7) and in Western Australia (15,22). From 1990 to 
2000, 8.3 days were saved per inpatient episode (7). The decline to 4.6 days saved in 2000–
2010 may indicate a shift in the system’s investment in community care.
Compared with the non-CTO cohort, the CTO cohort had more severe and clinically 
significant health and safety issues, particularly in the areas of aggression, hallucinations or 
delusions, cognitive disturbance, and disturbances in relationships. The CTO group was 
characterized by persistent health and safety problems, as indicated by repeated long-term 
hospitalizations, as well as persistent clinically significant symptoms. Thus the findings 
provide added justification, under the legal requirement to “prevent future deterioration” (7), 
for the protective measures specified in a CTO treatment plan; these measures are 
considered in mental health board hearings, where independent assessments are conducted 
in the presence of rights advocates (24).
It remains an open question with respect to the need- for-treatment component of the CTO 
criteria whether the patient would fail to get needed treatment without the involuntary 
provisions of the law. Previous research has supported the “involuntary component” of the 
law; findings indicate that when patients were brought under CTO supervision, they 
increased their use of mental health care to the level of a voluntary population and that they 
stopped making use of this level of service after CTO termination (23). This finding is also 
consistent with results of a recent survey of caregivers, which reported that among those 
with experience caring for a person on a CTO, most believed that the CTO had been of 
benefit; in 89% of the cases, the person relapsed when the CTO was stopped and needed 
further treatment (25).
The CTO is a delivery system for available treatment; it is not a vaccine with a potential to 
have carryover effects once the order is terminated; it does not prevent the recurrence of 
episodes of mental illness. Therefore, the CTO is only as effective as the treatment delivery 
system in which it is embedded and the extent to which that system makes treatment and 
supervision available (26). At the outset of this second decade of research on CTO use in 
Victoria’s mental health system, all state hospitals were closed, and the state governmental 
unit, composed of individuals who were viewed as effective community care advocates and 
whose unit’s mission was the promotion of enhanced community care, was disbanded (4). 
The system focus changed to one of integrated general medical and mental health care 
centered around the general hospital. Although community treatment during this second 
decade was available at a rate 40% higher for the CTO cohort than for the non-CTO cohort 
(26.6 contacts versus 16.1 contacts per community episode), the actual number of treatment 
contacts per community care episode fell from 35.6 to 26.6 (25%) for the CTO cohort, 
compared with 1990–2000, and from 23.0 to 16.1 (30%) for the non-CTO cohort (7). Our 
previous work indicates that in this environment of more constrained resources, clinicians 
appear to have adopted a de facto triage system for investing their time in themost serious 
cases by discharging 15.9% of the patients with less severe symptoms prior to a CTO legal 
hearing and focusing on making the case for legal retention of patients with more serious 
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illness—the result being that only 2% of patients who remained on a CTO long enough to 
get to a hearing (at eight weeks after the CTO start date) were discharged after the hearing 
(24).
The objective of CTO community care contacts also seems to have changed. The analyses 
regarding the impact of community treatment days went from a negative relationship in the 
1990–2000 cohort, indicating that treatment days contributed to a reduction in inpatient days 
per episode over the decade, to a finding in 2000–2010 indicating that treatment days were 
associated with an increase of a fraction of a day in the duration of an inpatient episode in 
interaction with a CTO. These results appear to show that the objective of the community 
treatment delivered in the second decade changed from aggressive action to maintain people 
in the community to a focus on providing services when absolutely required, such as by 
following up with patients who had a longer hospital stay and posed greater risk on release, 
meeting patients’ special needs, dealing with crises, and salvaging potentially failing CTO-
associated community care episodes by bringing patients back to the hospital for needed 
treatment. In fact, 39% of the CTOs ended in patient rehospitalization.
The limitations of this study derive from its reliance on administrative data, which are not 
collected for purposes of research. Quality-of-life psychosocial assessments were based on 
clinician, not patient, perspectives. Future studies should take into account patients’ points of 
view (even if by a simple quantitative self-rating) when evaluating the impact of CTOs on 
quality of life. In addition, the analyses relied on correlational measures that did not yield 
full certainty of causal inference because of potential selection bias. Nevertheless, the study 
examined the experience of an entire population over the course of ten years, and it 
replicates and adds depth to previous findings. Also, no randomized controlled trials (RCTs) 
of outpatient commitment have been completed that randomized at the outset of an inpatient 
episode that was followed by release to a CTO—that is, as opposed to randomization at 
release from the hospital. Thus
RCTs discount and provide no documentation on a random basis of the saving of hospital 
days attributable to early release to a CTO (27,28), and by doing so they ignore the true 
contribution of the CTO to limiting hospitalization time. Furthermore, for ethical reasons, 
studies do not use random assignment with individuals who are believed to be dangerous, 
which, as demonstrated in this study, is a core behavioral criterion that separates those 
placed on a CTO from those not placed on a CTO. As a consequence, completed RCTs 
involving outpatient commitment suffer from selection bias. If strict causal inference limits 
are used, then the conclusions of those studies apply only to patients who are not deemed to 
be dangerous—that is, those who are less likely to be selected for outpatient commitment 
(28). Finally, the issue of selection bias seems less pertinent to this study; the finding that 
hospital days were saved because patients assigned to CTOs were discharged to less 
restrictive community care is opposite to the expected finding, which is that the more 
severely ill CTO cohort would require more hospitalization than the non-CTO cohort.
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CONCLUSIONS
At inpatient admission, the problems of the CTO cohort were substantially more severe than 
those of the non-CTO cohort and were directly related to issues of health and safety. 
Although these problems abated somewhat by hospital discharge, it is likely that the CTO 
cohort had a continuing need for treatment given their history of a greater number of 
recurring hospitalizations and hospitalizations of longer duration. Given the procedural 
protections of the Victoria mental health board, CTO use that involves placing limits on 
patients’ behavior—measures that are included in the CTO framework—seems justified to 
prevent patients’ future deterioration.
The CTO is a delivery system designed to address the need for treatment in a least restrictive 
manner—one that reduces the need for inpatient care. To the extent that CTO placement was 
associated with reduced inpatient days during an illness episode, it appears to have achieved 
this objective. Questions remain as to whether the supervision provided by CTOs enables 
patients to receive unsought but required treatment that protects their health and safety.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. HoNOS ratings of problem area severity at inpatient admission and discharge for 
CTO and non-CTO cohortsa
a
 Problem areas are rated on Health of the Nation Outcome Scales on a scale from 0, no 
problem, to 4, extremely problematic. Clinicians’ ratings were rounded to the closest 
clinically descriptive anchor point. CTO, community treatment order
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